United Bank’s Abbott Laboratories Position
Does United Bank own Abbott Laboratories (ABT)? Yes — 105.8K shares worth $11M (+1.39% of its 13F portfolio) as of Q1 2026, up from 96.8K shares the prior filed quarter.
Position Value
$11M
Q1 2026
Shares
105.8K
% of Portfolio
+1.39%
Quarters Held
28
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 105.8K | $11M | +1.39% |
| Q4 2025 | 96.8K | $12M | +1.60% |
| Q3 2025 | 108.7K | $15M | +1.73% |
| Q2 2025 | 115.1K | $16M | +1.87% |
| Q1 2025 | 117.9K | $16M | +1.99% |
| Q3 2024 | 137.9K | $16M | +1.83% |
| Q2 2024 | 136.9K | $14M | +1.76% |
| Q1 2024 | 143.8K | $16M | +1.95% |
| Q4 2023 | 153.7K | $17M | +2.12% |
| Q3 2023 | 157.7K | $15M | +2.01% |
| Q2 2023 | 160.5K | $17M | +2.15% |
| Q1 2023 | 163.8K | $17M | +2.12% |
| Q4 2022 | 161.6K | $18M | +2.49% |
| Q3 2022 | 158.7K | $15M | +2.36% |
| Q2 2022 | 157.8K | $17M | +2.57% |
| Q1 2022 | 156.5K | $19M | +2.44% |
| Q4 2021 | 160.9K | $23M | +2.78% |
| Q3 2021 | 163.2K | $19M | +2.58% |
| Q2 2021 | 162.0K | $19M | +2.52% |
| Q1 2021 | 165.4K | $20M | +2.72% |
| Q4 2020 | 169.8K | $19M | +2.78% |
| Q3 2020 | 172.6K | $16M | +2.86% |
| Q1 2020 | 165.8K | $13M | +2.84% |
| Q4 2019 | 165.1K | $14M | +2.48% |
| Q3 2019 | 169.5K | $14M | +2.59% |
| Q2 2019 | 185.6K | $16M | +2.61% |
| Q1 2019 | 177.0K | $14M | +2.55% |
| Q4 2018 | 198.4K | $14M | +2.98% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See United Bank’s full portfolio or all institutional holders of ABT.